Literature DB >> 1431253

Recombinant murine interferon-gamma reversibly activates rat alveolar macrophages to kill Legionella pneumophila.

S J Skerrett1, T R Martin.   

Abstract

The interaction of interferon (IFN)-gamma, rat alveolar macrophages, and Legionella pneumophila was studied in vitro to define the effector cell potential of alveolar macrophages against an intracellular pathogen in a model in which the efficacy of IFN-gamma could be tested in vivo. Alveolar macrophages preincubated with IFN-gamma up-regulated Ia antigen and killed 0.5-4 logs of L. pneumophila over 4 days compared with 1-2 logs of bacterial growth in untreated cells. The bactericidal effect was dose dependent, evident over a wide range of bacterial inocula, and not suppressed by hydrocortisone. Preincubation with IFN-gamma was unnecessary and insufficient, as intracellular replication was reversed by exposure to IFN-gamma up to 48 h after infection, and neutralization of IFN-gamma after infection permitted bacterial growth. IFN-gamma thus converts alveolar macrophages from target cells to effector cells in host defense against L. pneumophila and may be of therapeutic benefit in legionellosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431253     DOI: 10.1093/infdis/166.6.1354

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  12 in total

1.  Coinoculation with Hartmannella vermiformis enhances replicative Legionella pneumophila lung infection in a murine model of Legionnaires' disease.

Authors:  J Brieland; M McClain; L Heath; C Chrisp; G Huffnagle; M LeGendre; M Hurley; J Fantone; C Engleberg
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Interferon-inducible protein 10, but not monokine induced by gamma interferon, promotes protective type 1 immunity in murine Klebsiella pneumoniae pneumonia.

Authors:  Xianying Zeng; Thomas A Moore; Michael W Newstead; Jane C Deng; Steven L Kunkel; Andrew D Luster; Theodore J Standiford
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Roles for tumor necrosis factor alpha and nitric oxide in resistance of rat alveolar macrophages to Legionella pneumophila.

Authors:  S J Skerrett; T R Martin
Journal:  Infect Immun       Date:  1996-08       Impact factor: 3.441

4.  Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines.

Authors:  K Tateda; T Matsumoto; Y Ishii; N Furuya; A Ohno; S Miyazaki; K Yamaguchi
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

5.  Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts.

Authors:  J C Deng; K Tateda; X Zeng; T J Standiford
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Legionella pneumophila growth restriction in permissive macrophages cocultured with nonpermissive lipopolysaccharide-activated macrophages.

Authors:  S Arata; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

7.  Induction of interleukin-4 (IL-4) by legionella pneumophila infection in BALB/c mice and regulation of tumor necrosis factor alpha, IL-6, and IL-1beta.

Authors:  C Newton; S McHugh; R Widen; N Nakachi; T Klein; H Friedman
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

8.  Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice.

Authors:  S Salins; C Newton; R Widen; T W Klein; H Friedman
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

9.  In vivo regulation of replicative Legionella pneumophila lung infection by endogenous tumor necrosis factor alpha and nitric oxide.

Authors:  J K Brieland; D G Remick; P T Freeman; M C Hurley; J C Fantone; N C Engleberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease.

Authors:  J Brieland; P Freeman; R Kunkel; C Chrisp; M Hurley; J Fantone; C Engleberg
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.